Briguglio Matteo, Bona Alberto, Porta Mauro, Dell'Osso Bernardo, Pregliasco Fabrizio Ernesto, Banfi Giuseppe
IRCCS Orthopedic Institute Galeazzi, Scientific Direction, Milan, Italy.
Department of Neurosurgery, ICCS Istituto Clinico Città Studi, Milan, Italy.
Front Physiol. 2020 Jun 5;11:671. doi: 10.3389/fphys.2020.00671. eCollection 2020.
The respiratory condition COVID-19 arises in a human host upon the infection with SARS-CoV-2, a coronavirus that was first acknowledged in Wuhan, China, at the end of December 2019 after its outbreak of viral pneumonia. The full-blown COVID-19 can lead, in susceptible individuals, to premature death because of the massive viral proliferation, hypoxia, misdirected host immunoresponse, microthrombosis, and drug toxicities. Alike other coronaviruses, SARS-CoV-2 has a neuroinvasive potential, which may be associated with early neurological symptoms. In the past, the nervous tissue of patients infected with other coronaviruses was shown to be heavily infiltrated. Patients with SARS-CoV-2 commonly report dysosmia, which has been related to the viral access in the olfactory bulb. However, this early symptom may reflect the nasal proliferation that should not be confused with the viral access in the central nervous system of the host, which can instead be allowed by means of other routes for spreading in most of the neuroanatomical districts. Axonal, trans-synaptic, perineural, blood, lymphatic, or Trojan routes can gain the virus multiples accesses from peripheral neuronal networks, thus ultimately invading the brain and brainstem. The death upon respiratory failure may be also associated with the local inflammation- and thrombi-derived damages to the respiratory reflexes in both the lung neuronal network and brainstem center. Beyond the infection-associated neurological symptoms, long-term neuropsychiatric consequences that could occur months after the host recovery are not to be excluded. While our article does not attempt to fully comprehend all accesses for host neuroinvasion, we aim at stimulating researchers and clinicians to fully consider the neuroinvasive potential of SARS-CoV-2, which is likely to affect the peripheral nervous system targets first, such as the enteric and pulmonary nervous networks. This acknowledgment may shed some light on the disease understanding further guiding public health preventive efforts and medical therapies to fight the pandemic that directly or indirectly affects healthy isolated individuals, quarantined subjects, sick hospitalized, and healthcare workers.
新冠病毒肺炎(COVID-19)是人类宿主感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2)后出现的一种呼吸道疾病。2019年12月底,在中国武汉爆发病毒性肺炎后,这种冠状病毒首次被确认。在易感个体中,全面爆发的COVID-19可能会因病毒大量增殖、缺氧、宿主免疫反应失调、微血栓形成和药物毒性而导致过早死亡。与其他冠状病毒一样,SARS-CoV-2具有神经侵袭潜力,这可能与早期神经系统症状有关。过去,感染其他冠状病毒患者的神经组织显示有大量浸润。感染SARS-CoV-2的患者通常会出现嗅觉障碍,这与病毒进入嗅球有关。然而,这种早期症状可能反映的是鼻腔增殖,不应与病毒进入宿主中枢神经系统相混淆,而在大多数神经解剖区域,病毒可通过其他传播途径进入中枢神经系统。轴突、跨突触、神经周围、血液、淋巴或特洛伊木马途径可使病毒从外周神经网络获得多种进入途径,最终侵入大脑和脑干。呼吸衰竭导致的死亡也可能与肺神经网络和脑干中心的呼吸反射因局部炎症和血栓引起的损伤有关。除了与感染相关的神经系统症状外,宿主康复数月后可能出现的长期神经精神后果也不能排除。虽然我们的文章并未试图全面理解宿主神经侵袭的所有途径,但我们旨在促使研究人员和临床医生充分考虑SARS-CoV-2的神经侵袭潜力,这种潜力可能首先影响外周神经系统靶点,如肠道和肺神经网络。这一认识可能有助于进一步了解该疾病,从而指导公共卫生预防工作和医学治疗,以应对这场直接或间接影响健康隔离个体、隔离对象、患病住院患者和医护人员的大流行。